The central result showed that patients with high PNI or low PLR had significantly better 3-year overall survival (OS) and progression-free survival (PFS) than those with low PNI or high PLR.
Current Oncology · 4 authors, 1 centre
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The central result showed that patients with high PNI or low PLR had significantly better 3-year overall survival (OS) and progression-free survival (PFS) than those with low PNI or high PLR.
The central result showed that patients with high PNI or low PLR had significantly better 3-year overall survival (OS) and progression-free survival (PFS) than those with low PNI or high PLR. Multivariate Cox regression analysis identified PNI and PLR as independent factors influencing OS. Treatment efficacy was defined by WHO criteria. Limitations include the small sample size, retrospective single-center design, and the lack of consensus on optimal cut-off values.